London-based Iq Sense Technology secures £110k for animal biosensing platform

Monitoring real-time biochemical markers and vital signs in animals is the focus of Iq Sense Technology Ltd, a London-based developer of biosensing platforms. The business integrates implantable microchips with wearable technology to track activity and health trends for pets, livestock, and the equine sector. These tools are designed to assist veterinarians with early disease detection and support sustainability goals within animal management.

A recent funding round raised an estimated £110k, resulting in an estimated post-money valuation of £2.4m. These figures are derived from documentation filed in June (following an allotment in March).

Incorporated in January 2025, the business operates within the biotechnology research and development sector. The platform aims to improve animal welfare by providing continuous data on physiological changes.